Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
6.34
-0.22 (-3.35%)
At close: Aug 27, 2026, 4:00 PM EDT
6.40
+0.06 (0.95%)
After-hours: Aug 27, 2026, 7:30 PM EDT
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $652.99 million as of August 27, 2026. Its market cap has increased by 603.03% in one year.
Market Cap
652.99M
Enterprise Value
518.88M
1-Year Change
603.03%
Ranking
Category
Stock Price
$6.34
ChartMarket Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $652.99M, a decrease of -19.05%. That is a compound annual growth rate of -3.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 651.96M | 172.84% |
| Dec 31, 2025 | 238.95M | 147.03% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 703.10M |
| Phathom Pharmaceuticals | 688.66M |
| AgomAb Therapeutics NV | 688.11M |
| OmniAb | 686.24M |
| Eikon Therapeutics | 673.27M |
| CorMedix | 665.64M |
| MapLight Therapeutics | 654.13M |
| Contineum Therapeutics | 643.32M |